Skip to content
Alivexis, Inc.
Unveiling the Future of Medicine
Menu
Home
Science
Pipeline
About Us
News
Public Notice
Contact Us
日本語
News
News
Modulus Discovery Announces Signing of Research Data Transfer Agreement with Astellas Pharma Inc.
- 30 May, 2019
Modulus Discovery Announces Signing of Collaboration Agreement with Tokyo Institute of Technology
- 09 May, 2019
Modulus Discovery Announces Senior Appointments including Jon Mason as Scientific Advisor
- 28 January, 2019
Modulus Discovery Announces the Initiation of a Research Collaboration with Prof. Tsutomu Suzuki, University of Tokyo
- 31 October, 2018
Modulus Discovery Announces Signing of a Multi-Target Research Collaboration with Professor Osamu Nureki, University of Tokyo
- 04 September, 2018
Modulus Raises 800M Japanese Yen for Its Series A Funding Round
- 09 August, 2018
Modulus Announces the Appointment of Former Senior Pharma Executive, Professor Wataru Uchida, as Scientific Advisor
- 31 July, 2018
Modulus Discovery Announces the Appointment of Hiroko Nishimoto As Advisor
- 01 June, 2018
Modulus Discovery Announces the Appointment of Taisuke Takahashi, Ph.D. as Vice President and Head Of Chemistry
- 01 April, 2018
Modulus Discovery Announces the Appointment of Yoh Terada, Ph.D. as Chief Scientific Officer
- 02 January, 2018
Previous
Next
Press & Media Contact
Email address protected by JavaScript.
Please enable JavaScript to contact me.
Latest Release
Alivexis to Present at ACS Spring Conference
Alivexis Announces Notice of U.S. Patent Registration for Novel Cathepsin C Inhibitor
Alivexis and OHARA Pharmaceutical Co., Ltd. to Collaborate on Selected Drug Targets
Alivexis Announces Receipt of Intention to Exercise Option Right from Astellas Pharma Inc. for Collaboration on Novel Drug Target
Notice of Selection for the Ministry of Economy, Trade and Industry’s Domestic Generative AI Development Strengthening Project “GENIAC”
